Intra-Cellular Therapies Inc (ITCI)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Sharon Mates |
| Employees: | 560 |
| Web site: | intracellulartherapies.com |
|
135 ROUTE 202/206, SUITE 6, BEDMINSTER, NJ, 07921
(646) 440-9333
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Intra-Cellular Therapies, Inc. develops novel drugs for the treatment of neuropsychiatric and neurologic diseases. The company offers CAPLYTA for schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for bipolar depression, as well as to treat auti® spectrum disorder.
Please log in first to see chart